Hovione announced that it appointed a vice-president of R&D to work directly with client drug development projects.
On Jan. 12, 2015, Hovione announced that it appointed Filipe Gaspar, PhD, as vice-president of research and design (R&D) for the company. Gaspar, who will report to Hovione’s chief executive, Guy Villax, will lead teams that serve client drug development projects in Lisbon, Portugal, and New Jersey. Gaspar, a chemical engineer, joined Hovione in 2003 as a manufacturing engineer, and moved to R&D in 2004.
“We are very pleased to have Filipe running our R&D. Filipe brings great science and leadership skills. For the last 10 years Filipe has been the driving force behind our Particle Engineering, and if we have four new drugs today on the market it is because he and his team made sure we had the right capabilities, know-how and ability to deliver,” said Guy Villax in a press release.
